WANG YULUN 4
4 · Teladoc Health, Inc. · Filed Dec 16, 2020
Insider Transaction Report
Form 4
WANG YULUN
Head of Research & Development
Transactions
- Exercise/Conversion
Common Stock
2020-12-14$16.92/sh+2,500$42,300→ 2,500 total - Exercise/Conversion
Common Stock
2020-12-15$16.92/sh+4,500$76,140→ 4,500 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-12-14−2,500→ 57,365 totalExercise: $16.92Exp: 2026-07-13→ Common Stock (2,500 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-12-15−4,500→ 52,865 totalExercise: $16.92Exp: 2026-07-13→ Common Stock (4,500 underlying) - Sale
Common Stock
2020-12-14$199.24/sh−2,500$498,100→ 0 total
Footnotes (1)
- [F1]The option vested in full on July 1, 2020.